Reckitt is dialing up its investment in China with plans to open a global research and development center of excellence in Shanghai.
Reckitt Eyes Greater Slice Of China Market With R&D Center Investment
Reckitt is investing over $40m to build a dedicated Chinese R&D center of excellence in Shanghai as it looks to capitalize on the double-digit sales growth it has recorded in the world's most populous market over recent years.
More from Strategy
More from Business
• By
Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”
• By
A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen.
• By
Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.